International Journal of Diabetes Research
p-ISSN: 2163-1638 e-ISSN: 2163-1646
2012; 1(1): 7-17
doi: 10.5923/j.diabetes.20120101.02
Omar H M 1, Saad El-dien H. M. 2, Saeed M A 1, Al-Salahy M. B. 1, Abel-Tawab H. S. 1
1Zoology Department, Faculty of Science, Assiut University, Assiut, 71516, Egypt
2Histology Department, Faculty of Medicine- Assiut University, Assiut, 71516, Egypt
Correspondence to: Omar H M , Zoology Department, Faculty of Science, Assiut University, Assiut, 71516, Egypt.
Email: |
Copyright © 2012 Scientific & Academic Publishing. All Rights Reserved.
Insulin dependent diabetes mellitus is a chronic metabolic disorder that continues to present a major worldwide health problem. It characterized by high level of glucose in blood due to deficiency of insulin. Generation of ROS is thought to mediate the cytotoxic action of alloxan on the pancreatic ß-cell and play an important role in the complication of diabetes. The aim of the present work to evaluate the efficacy of antioxidant α-lipoic acid and N-acetylcysteine to ameliorate the oxidative stress in hepatic tissue that induced by alloxan treatment in rabbits. Thirty-two male white rabbits were used in the present study classified into four groups. Group worked as normal control group, 2nd worked as untreated diabetic rabbits, 3rd and 4th groups diabetic rabbits treated with α-lipoic acid and N-acetyl cysteine respectively. Diabetic rabbits showed weigh loss, increase in relative liver weight, plasma glucose level and ALT activity. Also, showed morphological changes in the liver with increased in LPO, NO, CP and DNA fragmentation % and alteration in the non-enzymatic antioxidant levels (Vit E and GSH) and enzymatic antioxidant activities (CAT, SOD, GPx, GR, GGT, and GST) compared to control. Treatment of diabetic rabbits with either α-lipoic acid or N-acetyl cysteine overcome the loss of body weight gain and normalized relative liver weight, plasma glucose and ALT activity. Moreover, treatment improves the oxidative tress parameters and morphological changes that induced by alloxan and hyperglycemia. Conclusion: oxidative stress in alloxan induced diabetic rabbits plays a crucial role in hepatic degenerative changes. Treatment of diabetic rabbits with α-lipoic acid or N-acetyl cysteine caused normoglycemia and liver cell reprogramming due to its antioxidant activities. Beneficial action seems to result mainly from direct scavenging of ROS and restoring GSH redox state.
Keywords: Diabetes, Alloxan, Α Lipoic Acid, N-Acetyl Cysteine, Oxidative Stress, Liver and Rabbits
|
|
|
Figure 1-5. |
Figure 6-17. |
[1] | Davis, J.L.; Mendiratta, Jr.S and May J.M. (1998): Similarities in the metabolism of alloxan and dehydroascorbate in human erythrocytes. Biochem. Pharmacol., 55:1301-1307. |
[2] | Malaisse, W.J.; Malaise-Lagae, F.; Sener, A. and Pipeleers, D.G. (1982): Determinants of the selective toxicity of alloxan to the pancreatic ß cell. Proc. Natl. Acad. Sci. USA, 79: 927–930. |
[3] | Wolf, G.; Chen, S. and Ziyadeh, F. N. (2005): Perspectives in diabetes from the periphery of the glomerular capillary wall toward the center of disease podocyte injury comesofage in diabetic nephropathy. Diabetes, 54: 1626-1634. |
[4] | Khansari, N.; Shakiba, Y. and Mahmoudi, M. (2009): Chronic inflammation and oxidative stress as a major cause of age- related diseases and cancer. Recent Patents on Inflammation & Allergy Drug Discovery, 3, 73-80 73 |
[5] | Evans, J.L. and Goldfine, I.D. (2000): α-Lipoic acid: a multi-functional antioxidant that improves insulin sensitivity in patients with type II diabetes. Diab. Technol.Therap., 2:401-413. |
[6] | Packer,L.; Witt, E.H. and Tritscher, H.J.(1995): Alpha-lipoic acid as a biological antioxidant. Free Radic. Biol. Med., 19:227-250. |
[7] | Borcea, V.; Nourooz-Zadeh, J.; Wolff, S.P.; Klevesath, M.; Hofmann, M.; Urich, H.; Wahl, P.; Ziegler, R.; Tritschler, H.; Halliwell, B. and Nawroth, P.P. (1999): -lipoic acid decreases oxidative stress even in diabetic patients with poor glycemic control and albuminuria. Free Radic. Biol. Med., 26: 1495-1500. |
[8] | Blesa, S.; Cortijo, J.; Mata, M.; Serrano, A.; Closa, D.; Santangelo, F.; Estrela, J.M.; Suchankova, J. and Morcillo, E.J. (2003): Oral N-acetyl cysteine attenuates the rat pulmonary inflammatory response to antigen. Eur. Respir. J., 21: 394–400. |
[9] | Haber, C.A.; Lam, T.K.T.; Yu, J.Z.; Gupta, N.; Goh, T.; Bogdanovic, E.; Giacca, A. and Fantus, I.G. (2003): N-acetylcysteine and taurine prevent hyperglycemia-induced insulin resistance in vivo: possible role of oxidative stress. Am. J. Physiol., 285: 744–753. |
[10] | Wang, A.L.; Wang, J.P.; Wang, H.; Chena, Y.H.; Zhao, L.; Wang, L.S.; Wei, W. and Xu, D.Z. (2006): A dual effect of N-acetyl cysteine on acute ethanol-induced liver damage in mice. Hepat. Res., 34: 199–206. |
[11] | Majanol, P.L.; Medina, J.; Zubı´a, I.; Sunyer, L; Lara-Pezzi, E.; Guez A.M.; Lo´pez-Cabrera, M. and Moreno-Otero, M. (2004): N-Acetyl cysteine modulates inducible nitric oxide synthase gene expression in human hepatocytesq. J. Hepatology, 40: 632–637. |
[12] | Szkudelski, T. (2001): The Mechanism of alloxan and streptozotocin action in ß cells of the rat pancreas. Physiol. Res., 50: 536-546. |
[13] | Trinder, P. (1969): Quantitative determination of glucose using the GOP-PAP method. Clin. Biochem., 6: 24-27. |
[14] | Young, D. S. Ed., Effects of drugs on clinical laboratory tests. 3rd ed. Washington, DC: AACC Press, 1990. |
[15] | Lowry, O. H.; Rosebrough, N. J.; Farr, A. L. and Randall, R.J. (1951): Protein measurement with the Folin phenol reagent. J. Biol. Chem., 41:1863-1870. |
[16] | Ding, A. H.; Nathan, C. F. and Stuchr, D. J. (1988): Release of reactive nitrogen intermediate and reactive oxygen intermediate from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J. Immunol., 141:2407-2412. |
[17] | Ohkawa, H.; Ohishi, N. and Yagi, K. (1979): Assay for lipid peroxides in animal tissue by thiobarbaturic acid reaction. Anal. Biochem., 95: 351-358. |
[18] | Stadtman, E. R. and Levine, R. L. (2000): Protein oxidation. Ann. NY Acad. Sci., 899: 191-208. |
[19] | Kurita-Ochiai, T.; Fukushima, K. and Ochiai, K. (1999): Lipopolysaccharide stimulates butyric acid– induced apoptosis in human blood mononuclear cells. Infect. Immun., 67(1): 22-29. |
[20] | Misra, H. P. and Fridovich, I. (1972): The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J. Biol. Chem., 247: 3170-3175. |
[21] | Luck, H., Catalase in: Bergmer H-U, Ed., Methods of enzymatic analysis. Academic Press, New York, pp. 885-888, 1963. |
[22] | Habig, W. H.; Pabst, M. J. and Jokoby, W. B. (1974): Glutathion s-transferase. J. Biol. Chem., 249: 7130-7139. |
[23] | Meister, A.; Tate, S.S. and Griffith, O.W. (1981): Gamma-glutamyl transpeptidase. Methods in Enzymology, 77: 237-253. |
[24] | Mohandas, M.; Marshall, J.J.; Duggin, GG.; Horvath, JS. and Tiller, D. (1984): Differential distribution of glutathione and glutathione related enzymes in rabbit kidney. Cancer Res., 44: 5086-5091. |
[25] | Carlberg, L. and Mannerick, B. (1975): Glutathione level in rat brain. J.Biol.Chem., 250:4575-4580. |
[26] | Beutler, E.; Duron, O. and Kelly, B. M. (1963): Improved method for the determination of blood glutathione. J. Lab. Clin. Meth., 61: 882-888. |
[27] | Roe, J. H. Standard methods of clinical chemistry. Vol. 3 edited David Selgson Acad. Press. New York, p. 35, 1961. |
[28] | Drury, R. A. B. and Wallington, E. A. Carletion’s histological technique. Oxford. New York. Toronto. Oxford University Press, 1980. |
[29] | Johannessen, J. Instruction and techniques in electron microscopy in human medicine. Mchqraw-Hill Int.Book.Co, 1978. |
[30] | Campos, K.E.; Diniz, Y.S.; Cataneo, A.C.; Faine, L.A.; Alves, M.J. and Novelli, E.L. (2003): Hypoglycaemic and antioxidant effects of onion, Allium cepa: dietary onion addition, antioxidant activity and hypoglycemic effects on diabetic rats. Internat. J. Food Sci. Nutr., 54 (3): 241–246. |
[31] | El-Demerdash, F.M.; Yousef, M.I. and Abou El-Naga, N.I. (2005): Biochemical study on the hypoglycemic effects of onion and garlic in alloxan-induced diabetic rats. Food Chem. Toxicol., 43: 57–63. |
[32] | Kumar, G.R. and Reddy, K.P. (1999): Reduced nociceptive responses in mice with alloxan induced hyperglycemia after garlic (Allium sativum) treatment. Indian J. Exp. Biol., 37: 662–666. |
[33] | Jain, R.C. and Vyas, C.R. (1975): Garlic in alloxan-induced diabetic rabbits. Amer. J. Clin. Nutr., 28: 684–685. |
[34] | Navarro, C. M.; Montilla, P. M.; Martin, A.; Jimenez, J. and Utrilla, P.M. (1993): Free radicals scavenger and antihepatotoxic activity of Rosmarinus. Plant Medicine, 59: 312–314. |
[35] | Sepici, A., Gurbuz, I., Cevik, C., Yesılada, E. (2004): Hypoglycaemic effects of myrtle oil in normal and alloxan-diabetic rabbits. J. of Ethnopharm., 93: 311–318. |
[36] | Gumieniczek, A. (2005): Effects of repaglinide on oxidative stress in tissues of diabetic rabbits. Diabetes Res. Clin. Pract., 68 (2): 89-95. |
[37] | Sailaja Devi, M.M. and Das, U.N. (2006): Effect of prostaglandins against alloxan-induced diabetes mellitus. Prostagl. Leukotri. Essent. Fat. Ac., 74: 39–60. |
[38] | Ugochukwu, N.H. and Figgers, C.L. (2007): Dietary caloric restriction improves the redox status at the onset of diabetes in hepatocytes of streptozotocin-induced diabetic rats. Chemico-Biolo. Interact., 165: 45–53. |
[39] | Rasouli, N.; Raue, U.; Miles, L.M.; Lu, T.; Di Gregorio, G.B.; Elbein, S.C. and Kern, P.A. (2005): Pioglitazone improves insulin sensitivity through reduction in muscle lipid and redistribution of lipid into adipose tissue. Am. J. Physiol., 288: 930–934. |
[40] | Elsner, M.; Gurgul-Convey, E. and Lenzen, S. (2006): Relative importance of cellular uptake and reactive oxygen species for the toxicity of alloxan and dialuric acid to insulin-producing cells. Free Radic. Biol. Med., 41: 825–834. |
[41] | Oliver, C.N., (1987): Inactivation of enzymes and oxidative modification of proteins by stimulated neutrophils. Arch. Biochem. Biophys., 253: 62-72. |
[42] | Bainy, A.C.D.; Saito, E.; Carvello, P.S.M. and Junqueira, V.B.C. (1996): Oxidative stress in gill, erythrocytes, liver and kidney of Nile tilapia (Oreochromis niloticus) from a polluted site. Aquat. Toxicol., 34: 151. |
[43] | Kubisch, H. M.; Wang, J.; Bray, T. M.; Phillips, J. P. (1997): Targeted overexpression of Cu/Zn superoxide dismutase protects pancreatic ß cells against oxidative stress. Diabetes, 46: 1563–1566. |
[44] | Odetti, P.; Pesce, C.; Traverso, N.; Menini, S.; Maineri, E. P.; Cosso, L.; Valentini, S.; Patriarca, S.; Cottalasso, D.; Marinari, U. M. and Pronzato, M. A. (2003): Comparative trial of N-acetyl cysteine, taurine, and oxerutin on skin and kidney damage in long-term experimental diabetes. Diabetes, 52: 499-505. |
[45] | Packer, L., Kraemer, K., and Rimbach, G. (2001): Molecular aspects of lipoic acid in the prevention of diabetes complications. Nutrition, 17: 888–895. |
[46] | Holmquist, L.; Stuchbury, G.; Berbaum, K.; Muscat, S.; Young, S.; Hager, K.; Engel, J. and Münch, G. (2007): Lipoic acid as a novel treatment for Alzheimer's disease and related dementias. Pharmacol. Therap., 113: 154–164. |
[47] | Hall, A.G. (1999): The role of glutathione in the regulation of apoptosis. Eur. J. Clin. Invest., 29: 238– 245. |
[48] | Tanuma, S. Apoptosis: Cell Survival or Death. Tokyo, Japan, University of Tokyo Press, pp 1-25, 1994. |
[49] | Powell, L.A.; Nally, S.M.; McMaster, D.; Catherwood, M.A. and Trimble, E.R. (2001): Restoration of glutathione levels in vascular smooth muscle cells exposed to high glucose conditions. Free Radic. Biol. Med., 31: 1149-1155. |
[50] | Brownlee, M. (2001): Biochemistry and molecular cell biology of diabetic complications. Nature, 414: 813-820. |
[51] | Murata, M.; Mizutani, M.; Oikawa, S.; Hiraku,Y. and Kawanishi, S. (2003): Oxidative DNA damage by hyperglycemia-related aldehydes and its markedenhancement by hydrogen peroxide. FEBS Lett., 554: 138–142. |
[52] | Yamamasu, S.; Sato, E.; Ogita, S. and Inoue, M. (1997): Role of glutathione metabolism and apoptosis in the regression of liver hemopoiesis. Free Radic. Biol. Med., 23(1): 100–109. |
[53] | Loven, D. P. and Oberley, L. W. Free radicals, insulin action and diabetes. In: Superoxide Dismutase, volume III Pathological States. Edited by Oberley, L.W., CRC Press, Inc. Boca Raton, Florida USA, PP. 152-189, 1985. |
[54] | Miyata, H.; Aozasa, O.; Ohta, S; Chang, T. and Yasuda, Y. (1993): Estimated daily intakes of PCDDs, PCDFs and non-ortho coplanar PCBs via drinking water in Japan. Chemosphere, 26: 1527. |
[55] | Zusterzeel, P. L. M.; Rutten, H.; Roelefs, H. M. J.; Peters, W.H.M. and Steegers, E.A.P. (2001): Protein carbonyls in decidua and placenta of pre-eclamptic women as markers of oxidative stress. Placenta, 22: 213-219. |
[56] | Hunt, J. V.; Dean, R. T. and Wolff, S. P. (1988): Hydroxyl radical production and autoxidative glycosylation. Glucose autoxidation as the cause of protein damage in the experimental glycation model of diabetes mellitus and ageing. Biochem. J., 256: 205. |
[57] | Bitar, M.S.; Wahid, S.; Pilcher, C.W. Al-Saleh, E. and Al-Mulla, F. (2004): Alpha-lipoic acid mitigates insulin resistance in Goto-Kakizaki rats. Horm. Metab. Res., 36: 542-549. |
[58] | Packer, L. (1998): Alpha-lipoic acid: a metabolic antioxidant which regulates NF-kappa B signal transduction and protects against oxidative injury. Drug Metab. Rev., 30: 245–275. |
[59] | Evans; J.L.; Goldfine, I.D.; Maddux, B.A. and Grodsky, G.M. (2003): Are oxidative stress-activated signaling pathways mediators of insulin resistance and β-cell dysfunction? Diabetes, 52:1-8. |
[60] | Pastore, A.; Federici, G.; Bertini, E. and Piemonte, F. (2003): Analysis of glutathione: Implication in redox and detoxification. Clin. Chim. Acta, 333: 19–39. |
[61] | Dincer, Y.; Aldemir, Z.; IIkova, H. and Akcay, T. (2002): Susceptibility of glutathione and glutathione related antioxidant activity to hydrogen peroxide in patients with type II diabetes: Effect of glycemic control. Clin. Biochem., 35: 295–301. |
[62] | Obrosova, I.G.; Fathallah, L.; Liu, E. and Nourooz-Zadeh, J. (2003): Early oxidative stress in the diabetic kidney: Effect of DL--lipoic acid. Free Radic. Biol. Med., 34(2): 186–195. |
[63] | Oguzhan, B.; Yilmaz, M.T.; Memisoglu, K.; Ferendeci, N.; Biyikh, M.; Karaaslan, N.; Civelek, V.; Arioglu, E.; Dinccag, N. and Buyukdevrim, S. (1993): Tissue glutathione content in streptozotocin diabetes: a proposal to explain the specificity of STZ action. Med. Sci. Res., 21: 29-30. |
[64] | Stevens, M.J. (2005): Redox-based mechanisms in diabetes. Antioxid. Redox Signal., 7: 1483-1485. |
[65] | Kwon, Y-W.; Masutani, H.; Nakamura, H.; Ishii, Y. and Yodoi, J. (2003): Redox regulation of cell growth and cell death. Biol. Chem., 384: 991–996. |
[66] | Arivazhagan, P.; Juliet, P. and Panneerselvam, C. (2000): Effect of Dl--lipoic acid on the status of lipid peroxidation and antioxidants in aged rats. Pharmacol. Res., 41 (3): 299–303. |
[67] | Winiarska, K.; Malinska, D.; Szymanski, K.; Dudziak, M. and Bryla, J. (2007): Lipoic acid ameliorates oxidative stress and renal injury in alloxan diabetic rabbits. Bioch., 90: 450-459. |
[68] | Fiordaliso, F.; Bianchi, R. and Staszewsky, L. (2004): Antioxidant treatment attenuates hyperglycemia–induced cardiomyocyte death in rats. JMOI Cell Cardiol., 37: 959–968. |
[69] | Ballatori, N.; Jacob, R.; Barrett, C. and Boyer, J.L. (1988): Biliary catabolism of glutathione and differential reabsorption of its amino acide constituents. Am. J. Physiol., 254: 1-7. |
[70] | Griffith, O.W. and Meister, A. (1980): Excretion of cysteine and gamma glutamylcysteine in human and experimental gamma glutamyl transpeptidase deficiency. Proc. Natl. Acad. Sci. USA, 77: 3384-3387. |
[71] | Kaviarasan, K.; Arjunan, M. M. and Pugalendi, K. V. (2005): Lipid profile, oxidant–antioxidant status and glycoprotein components in hyperlipidemic patients with/without diabetes. Clin. Chim. Acta, 362: 49–56. |
[72] | Afshari, A.T.; Shirpoor, A.; Farshid, A.; Saadatian, R.; Rasmi, Y.; Saboory, E.; Ilkhanizadeh, B. and Allameh A. (2007): The effect of ginger on diabetic nephropathy, plasma antioxidant capacity and lipid peroxidation in rats. Food Chem., 101: 148–153. |
[73] | Chaudhry, J.; Ghosh, N. N.; Roy, K. and Chandra, R. (2007): Antihyperglycemic effect of a new thiazolidinedione analogue and its role in ameliorating oxidative stress in alloxan-induced diabetic rats. Life Sci., 80: 1135-1142. |
[74] | Sakuma, S.; Gotoh, K.; Sadatoku, N.; Fujita, T. and Fujimoto, Y. (2004): Effects of antirheumatic gold compounds on the conversion of xanthine dehydrogenase to oxidase in rabbit liver cytosol in vitro. Life Sciences, 75:1211–1218. |
[75] | Savitha, S.; Tamilselvan, J.; Anusuyadevi, M. And Panneerselvam, C. (2005): Oxidative stress on mitochondrial antioxidant defense system in the aging process: Role of Dl--lipoic acid and L-carnitine. Clin. Chim. Acta, 355: 173–180. |
[76] | Biewenga, G.P.; Haenen, G.R. and Bast, A. (1997): The pharmacology of the antioxidant lipoic acid. Gen. Pharmacol., 29: 315– 331. |
[77] | Akca, T.; Canbaz, H.; Tataroglu, C.; Caglikulekci, M.; Tamer, L.; Colak, T.; Kanik, A.; Bilgin, O. and Aydin, S. (2005): The effect of N-acetyl cysteine on pulmonary lipid peroxidation and tissue damage. J. Surg. Res., 129: 38–45. |
[78] | Mates, J. M.; Perez-Gomez, C. and Nunez de Castro, I. (1999): Antioxidant enzymes and human diseases. Clin. Biochem., 32: 595–603. |
[79] | Lu, D.; Maulik, N.; Moraru, I.I.; Kreutzer, D.L. and Das, D.K. (1993): Molecular adaptation of vascular endothelial cells to oxidative stress. Am. J. Physiol., 264: C715–C722. |
[80] | Coudray, C.F.; Rock, E.; Coudray, C.; Grzelkowska, K.; Braesco-Azais, V.; Dardevet, D. and Mazur, A. (1999): Lipid peroxidation and antioxidant status in experimental diabetes. Clin. Chim. Acta, 284: 31-43. |
[81] | Tribe, R.M. and Poston, L. (1996): Oxidative stress and lipids in diabetes: A role in endothelium vasodilator dysfunction. Vasc. Med., 1: 195-206. |
[82] | Pereira, B.; Costa Rosa, L.F.B.; Safi, D.A.; Bechara, E.J.H. and Curi, R. (1994): Superoxide dismutase, catalase and glutathione peroxidase activities in the lymphoid organs of diabetic rats. J. Endocrinol., 142: 161-165. |
[83] | Sekar, N.; Kanthasamy, A.; William, S.; Balasubramaniyan, N. and Govindasamy, S. (1990): Antioxidant effects of vanadate on experimental diabetic rats. Acta Diabetol. Lat., 27: 285–293. |
[84] | Saxena, A. K.; Srivastava, P.; Kale, R.K. and Baquer, N.Z. (1993): Impaired antioxidant status in diabetic rat liver. Effect of vanadate. Biochem. Pharmacol., 45: 539-542. |
[85] | Loven, D. P.; Schedl, H. P.; Wilson, H.; Daabes, T.T.; Stengink, L. D.; Diekus, M. and Oberley, L. W. (1986): Effect of insulin and oral glutathione on glutathione levels and superoxide dismutase activities in organs of rats with streptozotocin-induced diabetes. Diabetes, 35: 503-507. |
[86] | Meki, A. M. A. and Omar, H. M. (1997): Effect of garlic oil treatment as antioxidant on alloxan-induced diabetic rats. Bull. Egypt. Soc. Physiol. Sci., 17(1): 98-113. |
[87] | Kedziora–Kornatowska, K.Z.; Luciak, M. and Paszkowski (2000): Lipid peroxidation and activities of antioxidant enzymes in the diabetic kidney: Effect of treatment with angiotensin convertase inhibitors. JUBMS Life, 49: 303-307. |
[88] | Wohaieb, S.A. and Godin, D.V. (1987): Alterations in free radical tissue defense mechanism in streptozotocin-induced diabetes in rat. Diabetes, 36: 1014-1018. |
[89] | Grankvist, K.; Marklund S. L. and Taljedal I. B. (1981): Superoxide dismutase is a prophylactic against alloxan diabetes. Nature, 94: 158-160. |
[90] | Abdel-Rahman, M. S.; Elrakawy, F. I. and Iskander, F. A. (1992): Protection of ß cells against the effect of alloxan. Toxicol. Lett., 63: 155. |
[91] | Loven, D. P.; Schedl, H. P.; Oberley, L. W.; Daabes, T. T. and Stengink, L. D. (1983): Cu-Zn superoxide dismutase levels are depressed in various organs of streptozotocin-diabetic rats and restored by insulin or glutathione treatment. Fed. Proc. Fed. Am. Soc. Exp. Biol., 42: 504. |
[92] | Mukherjee, B.; Mukherjee, J.R. and Chatterjee, M (1994): Lipid peroxidation, glutathione levels and changes in glutathione-related enzyme activities in streptozotocin-induced diabetic rats. Immunol. Cell Biol., 72: 109-114. |
[93] | Omar, H. M.; Rosenblum, J. K.; Sanders, R. A. and Watkins III, J. B. (1998): Streptozotocin may provide protection against subsequent oxidative stress of endotoxin or streptozotocin in rats. J. Biochem. Molec. Toxicol., 12(3): 143-149. |
[94] | Thomas, H.; Schladt, L.; Knehr, M. and Oesch, F. (1989): Effect of diabetes and starvation on the activity of rat liver epoxide hydrolases, glutathione-S-transferases and peroxisomal beta-oxidation. Biochem. Pharmacol., 38: 4291-4297. |
[95] | Higuichi, Y. (1982): Lipid peroxides and -tocopherol in rat streptozotocin- induced diabetes mellitus. Acta Med. Okayama, 36: 165-175. |
[96] | Munteanu, A. and Zingg, J-M. (2007): Cellular, molecular and clinical aspects of vitamin E on atherosclerosis prevention. Molec. Aspects Med., 28: 538–590. |
[97] | Oberley, L.W.(1988): Free radicals and diabetes. Free Radic. Biol. Med., 5:113-124. |
[98] | Traber, M.G. and Atkinson, J. (2007): Vitamin E, antioxidant and nothing more. Free Radic. Biol. Med., 43(1): 4–15. |
[99] | Azzi, A. (2007): Molecular mechanism of -tocopherol action. Free Radic. Biol. Med., 43 (1): 16–21. |
[100] | [Rosenberg, H.R. and Culik, R. (1959): Effect of -lipoic acid on vitamin C and vitamin E deficiencies. Arch. Biochem. Biophys., 80: 86-93. |
[101] | Rahimi, R.; Nikfar, S.; Larijani, B. and Abdollahi, M. (2005): A review on the role of antioxidants in the management of diabetes and its complications. Biomed. Pharmaco-ther., 59: 365-373. |
[102] | Marsh, S.A.; Laursen, P.B.; Pat, B.K.; Gobe, G.C. and Coombes, J.S. (2005): Bcl-2 in endothelial cells is increased by vitamin E and alpha-lipoic acid supplementation but not exercise training. J. Mol. Cell Cardiol., 38 (3): 445–451. |
[103] | Gotoh, T. and Mori, M. (2006): Nitric oxide and endoplasmic reticulum Stress. Arterioscl. Thromb. Vasc. Biol., 26:1439-1446. |
[104] | Mayhan, W.C. and Patel, K.P. (1998): Treatment with dimethylthiourea prevents impaired dilatation of the basilar artery during diabetes mellitus. Am. J. Physiol., 274: H1895–H1901. |
[105] | Bhardwaj, R. and Moore, P.K. (1988): Increased vasodilator response to acetylcholine of renal blood vessels from diabetic rats. J. Pharm. Pharmacol., 40: 739–742. |
[106] | Kolb, H.; Kiesel, U.; Kroncke, K-D. and Kolb-Bachofen, V. (1991): Suppression of low dose streptozotocin induced diabetes in mice by administration of a nitric oxide synthase inhibitor. Life Sci., 49: 213-217. |
[107] | Corbett, J.A.; Sweetland, M.; Wang, J.L.; Lancaster, G.R. and McDaniel, M.L. (1993): Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human islets of Langerhans. Proc. Natl. Acad. SCi. USA, 90: 1731-1735. |
[108] | Garcia, M.; Morán, A.; Martín, M. L.; Mariette Barthelmebs, M. and Román, L. S. (2006): The nitric oxide synthesis/pathway mediates the inhibitory serotoninergic responses of the pressor effect elicited by sympathetic stimulation in diabetic rats. Eur. J. Pharmacol., 537: 126–134. |
[109] | De Marco, V.G.; Bosanquet, J.P.; Rawlani, V.R. and Skimming, J.W. (2005): Lipoic acid decreases exhaled nitric oxide concentrations in anesthetized endotoxemic rats. Vasc. Pharma., 43: 404 -410. |
[110] | Ca˘glıkülekci, M.; Pata, C.; Apac, D.D.; Dirlik, M.; Tamer, L.; Yaylak, F.; Kanik, F. and Aydin, S. (2004): The effect of N-acetyl cysteine (NAC) on liver and renal tissue inducible nitric oxide synthase (iNOS) and tissue lipid peroxidation in obstructive jaundice stimulated by lipopolysaccharide (LPS). Pharm. Res., 49: 227–238. |
[111] | Majanol, P.L.; Medina, J.; Zubia, I.; Sunyer, L.;Lara-Pezzi, E.; Guez, A.M; Lopez-Cabrera, M. and Moreno,-Otero, M. ( 2004): N-acetylcysteine modulates inducible nitric oxide synthase gene expression in human hepatocytes. J.Hepatology, 40:632-637. |
[112] | Myint, T.; Hoshi, S.; Ookawara, T.; Miyazawa, N.; Suzuki, K.; and Taniguchi, N. (1995): Immunological detection of glycated proteins in normal and streptozotocin-induced diabetic rats using anti hexitol-lysine IgG. Biochim.. Biophys. Acta, 1272: 73-79. |
[113] | Sakuma, S.; Gotoh, K.; Sadatoku, N.; Fujita, T. and Fujimoto, Y. (2004): Effects of antirheumatic gold compounds on the conversion of xanthine dehydrogenase to oxidase in rabbit liver cytosol in vitro. Life Science, 75:1211-1218. |
[114] | Kataoka, K.; Handa, H. and Nishizawa, M. (2001): Induction of cellular antioxidative stress genes through heterodimeric transcription factor Nrf2/Small Maf by antirheumatic gold (I) compounds. J. Biol. Chem., 276 (36): 34074–34081. |